News From the Epidemiology and Genomics Research Program
EGRP Cancer Epidemiology News
EGRP Cancer Epidemiology News is a monthly e-newsletter with information regarding funding opportunities related to cancer epidemiology, grantsmanship issues, research resources, and other relevant news.
Subscribe!
Sign up by entering your email address and selecting your preferences on the page that follows.
Subscribe to the E-NewsletterFeatured News Articles
2022: Year in Review
January 2023
This Year in Review issue considers EGRP's progress over the past year including leadership changes, new funding opportunities that scientific staff have developed, virtual webinars and workshops, and updated research resources.
Continue Reading
New Reflections on Cancer Control
December 2022
The 2022 Overview and Highlights report from NCI's Division of Cancer Control and Population Sciences (DCCPS) focuses on six future directions for cancer control and population sciences, in addition to the areas of science DCCPS continues to support.
Continue Reading
Funding Opportunities to Address Benefits and Harms of Cannabis Use Among Cancer Patients
November 2022
Although there has been a rapid increase in the availability of cannabis and cannabinoid products and substantial changes in their delivery methods, there is not yet enough information available regarding the harms and benefits of these substances during cancer treatment. Read our monthly newsletter to learn about NCI support for research addressing cannabis and cannabinoid use among cancer patients.
Continue Reading
Leadership Changes in NCI and DCCPS
October 2022
The weather isn't the only thing that's changing around here! Two significant leadership changes have taken place that we want to make sure the cancer research community is aware of.
Continue ReadingResearch Highlights
EGRP Research Highlights
Each year, the Epidemiology and Genomics Research Program publishes a Research Highlights list to showcase a selection of recent publications resulting from research projects in the EGRP grant portfolio.
View the 2021 Research Highlights